Salesforce's AI Wins and Shareholder Returns Battle Market Skepticism

Salesforce stock is down ~26% YTD despite robust AI growth with government contracts, strong Q4 earnings, and a massive $50B share buyback program. Investor sentiment on SaaS and AI costs weighs on shares.

Salesforce stock is caught in a curious tug-of-war. While the company secures major government contracts for its artificial intelligence platform and delivers robust financial results, its share price continues to languish, down roughly a third over the past year. This disconnect highlights investor concerns over the broader SaaS sector's future, even as Salesforce demonstrates operational strength.

The company's AI division, Agentforce, is gaining significant traction in the public sector. The U.S. Department of Labor is implementing the platform to power a 24/7 citizen assistance contact center. Simultaneously, the Veterans Health Administration (VHA) is integrating the system across more than 150 medical centers. These deals cement Salesforce's role as a critical infrastructure provider for government agencies prioritizing secure data processing and automation.

Financially, the company's performance remains solid. Fourth-quarter revenue for fiscal 2026 climbed 12.1% to $11.20 billion, with earnings per share of $3.81 handily beating the consensus estimate of $3.05. The Agentforce segment was a standout, with its annual recurring revenue surging 169% to $800 million. Looking ahead, management forecasts revenue could reach up to $46.2 billion for fiscal 2027.

Despite these fundamentals, the stock faces persistent pressure. Shares recently traded at 161.12 EUR, marking a decline of nearly 26% since the start of the year. Analysts point to a sector-wide reassessment, where the long-term costs and competitive threats of AI integration are being weighed against current growth valuations. General inflation worries are also weighing on technology stocks broadly.

In response, Salesforce is aggressively returning capital to shareholders. The board has authorized a share repurchase program of up to $50 billion, a significant expansion of its strategy. Furthermore, the stock recently traded ex-dividend. Shareholders of record are set to receive a quarterly payout of $0.44 per share on April 23, an increase of 5.8% that translates to an annualized yield of approximately 1.0%.

Wall Street's outlook is mixed. The average analyst price target sits at $280.21, with a consensus rating of "Moderate Buy." However, some firms have turned more cautious; Oppenheimer lowered its target from $275 to $250 in late February, while Monness maintained a neutral "Hold" rating in early April.

The next major test arrives with the release of first-quarter fiscal 2027 results, expected on May 27, 2026. Investors will be watching closely to see if the combined force of Agentforce's growth and the massive buyback program can finally stabilize the share price and shift the market's narrative.